Dept. of Integrative Physiology, Univ. of Colorado, Boulder, Campus Box 354, Boulder, CO 80309, USA.
Am J Physiol Regul Integr Comp Physiol. 2010 Dec;299(6):R1592-601. doi: 10.1152/ajpregu.00247.2010. Epub 2010 Sep 15.
We recently demonstrated that mRNA levels of three members of the CCAAT/enhancer binding factor (C/EBP) family of transcription factors are increased in skeletal muscle following 12 days of spaceflight. In the present study, we further explored the expression of C/EBP-δ in atrophying fast skeletal muscle by examining its expression in muscle from food-deprived (FD) mice, and investigated its role in regulating the expression of the secreted antigrowth factor myostatin. C/EBP-δ mRNA and protein levels were significantly increased by 2 days of food deprivation in the tibialis anterior (TA) muscle, and expression of both myostatin and C/EBP-δ mRNA during food deprivation was attenuated by injection with the glucocorticoid inhibitor RU486. The increase in myostatin mRNA levels with food deprivation appears to be at least partially transcriptionally driven, since levels of myostatin pre-mRNA were significantly increased in the TA muscle. C/EBP-δ mRNA levels and promoter activity were significantly increased by transfection of C(2)C(12) myotubes with a glucocorticoid receptor construct and 24 h of treatment with the synthetic glucocorticoid dexamethasone. Furthermore, activity of the C/EBP-δ promoter was significantly increased with as little as 1 h of dexamethasone treatment, while activity of the mouse myostatin promoter was only significantly increased with longer treatment periods of 24 h or more. Activity of the myostatin promoter-reporter construct was significantly increased in C(2)C(12) myotubes by cotransfection with expression constructs for C/EBP-α, -β, and -δ, with C/EBP-δ having the greatest effect. The myostatin promoter contains two potential C/EBP binding sequences, a CCAAT box, and a C/EBP binding element (CBE). Mutation of the CCAAT box attenuated basal myostatin promoter activity but potentiated C/EBP-δ-activated myostatin promoter activity in C(2)C(12) myotubes in vitro, while mutation of the CBE abolished glucocorticoid receptor and C/EBP-δ responsiveness. The present results support a model in which glucocorticoid-induced increases in C/EBP-δ expression may contribute to myostatin transcription during atrophic states.
我们最近的研究表明,在太空飞行 12 天后,三种 CCAAT/增强子结合因子(C/EBP)家族转录因子的 mRNA 水平在骨骼肌中增加。在本研究中,我们通过检测饥饿(FD)小鼠肌肉中的表达,进一步研究了 C/EBP-δ 在萎缩性快肌中的表达,并研究了其在调节分泌性抗生长因子肌抑素表达中的作用。在胫骨前肌(TA)中,C/EBP-δ mRNA 和蛋白水平在禁食 2 天后显著增加,并且注射糖皮质激素抑制剂 RU486 可减弱肌抑素和 C/EBP-δ mRNA 在禁食期间的表达。与禁食相关的肌抑素 mRNA 水平的增加似乎至少部分是转录驱动的,因为 TA 肌肉中的肌抑素前体 mRNA 水平显著增加。C/EBP-δ mRNA 水平和启动子活性通过用糖皮质激素受体构建体转染 C(2)C(12)肌管和用合成糖皮质激素地塞米松处理 24 小时而显著增加。此外,C/EBP-δ 启动子的活性在仅 1 小时的地塞米松处理下显著增加,而小鼠肌抑素启动子的活性仅在 24 小时或更长时间的处理后才显著增加。在 C(2)C(12)肌管中转染 C/EBP-α、-β 和 -δ 的表达构建体后,肌抑素启动子报告构建体的活性显著增加,其中 C/EBP-δ 的作用最大。肌抑素启动子包含两个潜在的 C/EBP 结合序列,CCAAT 盒和 C/EBP 结合元件(CBE)。CCAAT 盒的突变减弱了基础肌抑素启动子活性,但在体外 C(2)C(12)肌管中增强了 C/EBP-δ 激活的肌抑素启动子活性,而 CBE 的突变消除了糖皮质激素受体和 C/EBP-δ 的反应性。目前的结果支持这样一种模型,即糖皮质激素诱导的 C/EBP-δ 表达增加可能有助于萎缩状态下的肌抑素转录。